Related Experiment Video
Updated: Jul 21, 2026
06:24
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Staging pancreatic carcinoma by computed tomography.
I Montejo Gañán1, L F Ángel Ríos1, L Sarría Octavio de Toledo1
1Servicio de Radiodiagnóstico, Hospital Universitario Miguel Servet, Zaragoza, España.
Radiologia
|October 29, 2017
Summary
Pancreatic cancer staging is vital for treatment. Multidetector computed tomography (CT) is the preferred imaging method for pancreatic tumors, offering key insights into staging and treatment planning.
Area of Science:
- Oncology
- Radiology
- Gastroenterology
Background:
- Pancreatic carcinoma incidence is rising globally.
- Mortality rates for pancreatic cancer have remained largely unchanged over two decades.
- Effective treatment hinges on early diagnosis and precise staging.
Purpose of the Study:
- To review the current state of pancreatic adenocarcinoma staging.
- To highlight the applications and limitations of multidetector computed tomography (CT) in staging.
- To emphasize the importance of accurate staging for therapeutic decisions.
Main Methods:
- Review of current literature on pancreatic cancer staging.
- Focus on multidetector computed tomography (CT) as the primary imaging modality.
- Comparison of CT with other imaging techniques like MRI, PET-CT, EUS, and laparoscopy.
Main Results:
- Multidetector CT is the current gold standard for pancreatic tumor staging.
- CT provides essential information for surgical resectability assessment.
- Accurate staging via CT aids in minimizing surgical risks and improving patient outcomes.
Conclusions:
- Multidetector CT is crucial for staging pancreatic adenocarcinoma.
- Accurate staging impacts treatment strategies and patient survival.
- Continued research into CT applications and limitations is warranted.
